| Hepatocellular Carcinoma |
1 |
1 |
| Radiation Therapy |
0 |
0.99 |
| Biologic Therapy |
0 |
0.98 |
| Cancer |
0 |
0.6 |
| Metastasis |
0 |
0.52 |
| Liver |
0 |
0.5 |
| Clinical Research |
0 |
0.2 |
| Grant |
0 |
0.2 |
| Healthcare and Medical Technology |
0 |
0.2 |
| Tumor |
0 |
0.2 |
| Vein |
0 |
0.2 |
| Revenue and Practice Management |
0 |
0.17 |
| Tyrosine Kinase Inhibitor |
0 |
0.14 |
| Ablation |
0 |
0.1 |
| Angiogenesis Inhibitors |
0 |
0.1 |
| Board Certification |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Humanized Monoclonal Antibody |
0 |
0.1 |
| Immunotherapy |
0 |
0.1 |
| New York |
0 |
0.1 |
| Salary and Compensation |
0 |
0.1 |
| Tyrosine Kinase |
0 |
0.1 |